SCHEMBL7677074

SCHEMBL7677074

CN(C)c1ccccc1/C=C/C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.56
MAPT P10636 4/20 0.44
ALDH1A1 P00352 3/20 0.44
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 2/20 0.41
CCNC P24863 2/20 0.40
CDK8 P49336 2/20 0.40
NFE2L2 Q16236 3/20 0.39
NFKB1 P19838 2/20 0.39
JUN P05412 1/20 0.39
ALOX5 P09917 1/20 0.39
GSK3B P49841 1/20 0.39
TFEB P19484 1/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6561859 0.84 CA1 (0.56) PTPN1MAPTALDH1A1TP53SMN1; SMN2
SCHEMBL8534634 0.84 MAPT (0.59) PTPN1MAPTALDH1A1TP53SMN1; SMN2
SCHEMBL8534636 0.84 MAPT (0.59) PTPN1MAPTALDH1A1TP53SMN1; SMN2
SCHEMBL7455794 0.84 CA1 (0.56) PTPN1MAPTALDH1A1TP53SMN1; SMN2
SCHEMBL2328371 0.80 NFKB1 (0.50) PTPN1MAPTLMNACCNCCDK8
SCHEMBL12425723 0.79 HDAC8 (0.58) MAPTALDH1A1TP53SMN1; SMN2MEN1
SCHEMBL815585 0.79 MAPT (0.58) MAPTALDH1A1SMN1; SMN2LMNANFKB1
SCHEMBL815583 0.79 MAPT (0.58) MAPTALDH1A1SMN1; SMN2LMNANFKB1
SCHEMBL29523356 0.78 GSK3B (0.44) MAPTALDH1A1TP53SMN1; SMN2GAA
SCHEMBL20030390 0.77 MAPT (0.40) PTPN1MAPTALDH1A1TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414013-B1 KINASE INHIBITORS; ANTICANCER AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2002-07-02 US disclosed